T0	Participants 90 139	stage IIIB/IV non-small-cell lung cancer (NSCLC).
T1	Participants 288 337	stage IIIB/IV non-small-cell lung cancer (NSCLC).
T2	Participants 346 420	A total of 168 patients with previously untreated stage IIIB/IV NSCLC were
T3	Participants 1583 1598	advanced NSCLC.